GLP-1s might reduce risk of cancer. Researchers are asking why episode artwork

EPISODE · Jun 5, 2026 · 3 MIN

GLP-1s might reduce risk of cancer. Researchers are asking why

from All Things Considered · host Yuki Noguchi

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

Episode metadata supplied by the publisher feed · Published Jun 5, 2026

Embed this episode

NOW PLAYING

GLP-1s might reduce risk of cancer. Researchers are asking why

0:00 3:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of All Things Considered?

This episode is 3 minutes long.

When was this All Things Considered episode published?

This episode was published on June 5, 2026.

Can I download this All Things Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!